Averin Capital

Averin Capital is dedicated to identifying and accelerating high-performance healthcare companies, positioning itself at the forefront of the converging technology and biology sectors. Averin Capital focuses on key verticals including Artificial Intelligence in therapeutic development, diagnostic support, workflow optimization, insurance solutions, and predictive analytics. The firm is also deeply involved in Longevity initiatives, promoting early screening, preventative care, remote patient monitoring, and integrated care platforms.

Averin Capital is committed to data-driven care, emphasizing value-based models, real-world data applications, evidence-based practices, payment integrity, and the development of sustainable healthcare models. Furthermore, Averin Capital invests in deep technology, exploring synthetic biology, nanotechnology, personalized medicine, and genomics to drive future healthcare advancements. The company's primary address is in New York, NY, US, with an additional location in Boston, MA, US.

With a forward-looking approach, Averin Capital aims to harness the transformative potential of technology and biology to revolutionize healthcare. Averin Capital is actively shaping the future of healthcare through strategic investments and a focus on innovation. We invite the manager of Averin Capital to create a customized and exclusive company showcase and product listing on our platform.